1983XenobioticaRequires access

Acetylation of sulphanilamide in four marsupials and a monotreme

Stuart McLean, Heather Galloway, Stephen E. Butler, D. Whittle, Stewart C. Nicol

Open publisher page 5 citations

Abstract

1. The urinary metabolites of sulphanilamide (100 mg/kg, i.p.) have been studied in four marsupials (the Tasmanian devil, brushtail possum, pademelon and barred bandicoot), a monotreme (the echidna) and a eutherian (the rat). 2. All species excreted some unchanged sulphanilamide (20-30% of dose in 24 h). The major urinary metabolite in the devil, possum and pademelon was N4-acetylsulphanilamide (6-17%). This was less than that excreted by the rat (40%). These three marsupials and the rat also excreted small amounts of N1-acetyl and N1, N4-diacetylsulphanilamide. 3. The bandicoot and echidna were virtually unable to acetylate sulphanilamide, unlike the 16 other species of animals and birds in which this has been studied. The reason for this metabolic defect is unknown.

About this research paper

What this paper is about

1. The urinary metabolites of sulphanilamide (100 mg/kg, i.p.) have been studied in four marsupials (the Tasmanian devil, brushtail possum, pademelon and barred bandicoot), a monotreme (the echidna) and a eutherian (the rat). 2. All species excreted some unchanged sulphanilamide (20-30% of dose in 24 h). The major urinary metabolite in the devil, possum and pademelon was N4-acetylsulphanilamide (6-17%). This was less than that excreted by the rat (40%). These three marsupials and the rat also excreted small amounts of N1-acetyl and N1, N4-diacetylsulphanilamide. 3. The bandicoot and echidna were virtually unable to acetylate sulphanilamide, unlike the 16 other species of animals and birds in which this has been studied. The reason for this metabolic defect is unknown.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

1. The urinary metabolites of sulphanilamide (100 mg/kg, i.p.) have been studied in four marsupials (the Tasmanian devil, brushtail possum, pademelon and barred bandicoot), a monotreme (the echidna) and a eutherian (the rat). 2. All species excreted some unchanged sulphanilamide (20-30% of dose in 24 h). The major urinary metabolite in the devil, possum and pademelon was N4-acetylsulphanilamide (6-17%). This was less than that excreted by the rat (40%). These three marsupials and the rat also excreted small amounts of N1-acetyl and N1, N4-diacetylsulphanilamide. 3. The bandicoot and echidna were virtually unable to acetylate sulphanilamide, unlike the 16 other species of animals and birds in which this has been studied. The reason for this metabolic defect is unknown.

Key concepts: Bandicoot, Monotreme, Biology, Brushtail possum, Marsupial, Zoology, Metabolite, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Acetylation of sulphanilamide in four marsupials and a monotreme — Research Paper | ScholarLens